This move is the latest in a series of attempts by the Trump administration to eliminate DEI/DEIA programs and reduce NIH funding.

CAR T-cell therapy showed encouraging efficacy and good safety in newly diagnosed Ph-positive ALL,” the researchers wrote.

Atezolizumab may improve upon perioperative treatment with trastuzumab and chemotherapy in HER2+, locally advanced, resectable gastric or GEJ cancer, researchers say.

Progress has been made in reducing overall cancer mortality, largely driven by sustained declines in lung cancer,” the researchers wrote.